Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implementation study of long-acting injectable cabotegravir for HIV PrEP
RBR-8s3qz5sRecruiting
- Sponsor
- Evandro Chagas National Institute of Infectology
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cabotegravir in human immunodeficiency virus infection (HIV) (5 arms), sponsored by Evandro Chagas National Institute of Infectology. Started Oct 2023; status: recruiting.
02
Drugs
cabotegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on RBR-8s3qz5s.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8s3qz5s.